Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

372 ARTÍCULOS , VIENDO DEL 16 AL 30

Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease

Sabbagh MN, Schäuble B, Anand K, Richards D, Murayama S, Akatsu H, Takao M, Rowe CC, Masters CL, Barthel H, Gertz HJ, Peters O, Rasgon N, Jovalekic A, Sabri O, Schulz-Schaeffer WJ, Seibyl J.

J Alzheimers Dis. 2017;56(2):441-446. doi: 10.3233/JAD-160821.

Current opinion in Alzheimer's disease therapy by nanotechnology-based approaches

Ansari SA, Satar R, Perveen A, Ashraf GM.

Curr Opin Psychiatry. 2017 Mar;30(2):128-135. doi: 10.1097/YCO.0000000000000310.

The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial

Carotenuto A, Rea R, Traini E, Fasanaro AM, Ricci G, Manzo V, Amenta F.

J Alzheimers Dis. 2017;56(2):805-815. doi: 10.3233/JAD-160675.

Neurobiological arguments for a pathogenic multifactorial disconnective model of cognitive disorders from Alzheimer's disease in elderly people

Marinescu I, Enătescu VR, Ghelase ŞM, Marinescu D.

Rom J Morphol Embryol. 2017;58(4):1165-1173.

Insulin Resistance in Alzheimer Disease: p53 and MicroRNAs as Important Players

Gasiorowski K, Brokos B, Leszek J, Tarasov VV, Ashraf GM, Aliev G.

Curr Top Med Chem. 2017;17(12):1429-1437. doi: 10.2174/1568026617666170103161233.

Sundown Syndrome, Sleep Quality, and Walking Among Community-Dwelling People With Alzheimer Disease

Shih YH, Pai MC, Huang YC, Wang JJ.

J Am Med Dir Assoc. 2017 May 1;18(5):396-401. doi: 10.1016/j.jamda.2016.10.016. Epub 2017 Jan 2.

Drawing analysis in the assessment of patients with neurodegenerative diseases

Sitek EJ, Narożańska E, Konieczna S, Brockhuis B, Wieczorek D, Wszolek ZK, Sławek J.

Neurology. 2017 Jan 10;88(2):218-219. doi: 10.1212/WNL.0000000000003496.

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease

Moussa C, Hebron M, Huang X, Ahn J, Rissman RA, Aisen PS, Turner RS.

J Neuroinflammation. 2017 Jan 3;14(1):1. doi: 10.1186/s12974-016-0779-0.

A Perspective on Crocus sativus L. (Saffron) Constituent Crocin: A Potent Water-Soluble Antioxidant and Potential Therapy for Alzheimer's Disease

Finley JW, Gao S.

J Agric Food Chem. 2017 Feb 8;65(5):1005-1020. doi: 10.1021/acs.jafc.6b04398. Epub 2017 Jan 31.

Solanezumab: too late in mild Alzheimer's disease?

The Lancet Neurology.

Lancet Neurol. 2017 Feb;16(2):97. doi: 10.1016/S1474-4422(16)30395-7.

A Path Analysis of Dependence and Quality of Life in Alzheimer's Disease

Garre-Olmo J, Vilalta-Franch J, Calvó-Perxas L, López-Pousa S; CoDep-AD Study Group.

Am J Alzheimers Dis Other Demen. 2017 Mar;32(2):108-115. doi: 10.1177/1533317516688297. Epub 2017 Jan 22.

Acute renal failure caused by cilostazol in a patient with Alzheimer's disease

Nomoto H, Matsubara Y, Ichimiya Y, Arai H.

Geriatr Gerontol Int. 2017 Jan;17(1):171-172. doi: 10.1111/ggi.12760.

Assessing the Current State of Cognitive Frailty: Measurement Properties

Sargent L, Brown R.

J Nutr Health Aging. 2017;21(2):152-160. doi: 10.1007/s12603-016-0735-9.

A patient's experience in dementia care: Using the "lived experience" to improve care

Frank C, Forbes RF.

Can Fam Physician. 2017 Jan;63(1):22-26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias